Targeting NTRK in NSCLC
Podcast | English | 2022 | 32 Min
Image For Activity Cover
No Credit Offered
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.
Dr. Narjust Duma
Dr. Robert C. Doebele
Powered By